Segantii Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-415	Closed	-$77K	–	254
2017 Q1	$77K	Buy	+415	New	+$77K	0.01%	228